The central role of the intestinal microbiota in the progression and, equally, prevention of
metabolic dysfunction is becoming abundantly apparent. The symbiotic relationship …

The human gut is densely populated by commensal and symbiotic microbes (the “gut
microbiota”), with the majority of the constituent microorganisms being bacteria …

The recent identification of cannabinoid receptors and their endogenous lipid ligands has
triggered an exponential growth of studies exploring the endocannabinoid system and its …

Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric
infections and inflammatory conditions to disorders of motility, emesis and abdominal pain …

Coinciding with the increasing rates of cannabis abuse has been the recognition of a new
clinical condition known as Cannabinoid Hyperemesis Syndrome. Cannabinoid …

The recent emergence of a multitude of synthetic cannabinoids (SCs) has generated a
wealth of new information, suggesting the usefulness of stateoftheart on lato sensu …

Inflammatory bowel disease (IBD) is a general term used to describe a group of chronic
inflammatory conditions of the gastrointestinal tract of unknown etiology, including two …

This review compares the biological and physiological function of Sigma receptors [σRs] and
their potential therapeutic roles. Sigma receptors are widespread in the central nervous …

Cannabis is an excellent natural source of fiber and various bioactive cannabinoids. So far,
at least 120 cannabinoids have been identified, and more novel cannabinoids are gradually …

The emerging potential for the cannabinoid (CB) system in modulating gastrointestinal
inflammation has gained momentum over the last few years. Traditional and anecdotal use …